pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,130
stories
21d
As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safety
fiercebiotech
21d
Kennedy to deliver keynote for anti-vaccine group he once led
stat
22d
AstraZeneca’s newly approved pill fails frontline breast cancer study
biopharma dive
22d
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
biospace
22d
Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’
biospace
22d
STAT+: GSK touts lung cancer data from two drugs
stat
22d
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
biospace
22d
STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more
stat
22d
Scholar Rock SMA drug approved by FDA
biopharma dive
22d
AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger market
biospace
22d
Lilly cans early experimental obesity drug after ‘high bar’ not met
fiercebiotech
22d
Scholar Rock secures first FDA approval for muscle-targeting rare disease drug
biospace
22d
Scholar Rock gets FDA nod for spinal muscular atrophy drug
endpoints
22d
AstraZeneca’s next-gen SERD Etcamah disappoints in untreated advanced breast cancer
endpoints
22d
Definium says its LSD drug notched another Phase 3 win in anxiety disorder
endpoints
22d
STAT+: Definium’s LSD therapy eased anxiety in second large trial
stat
22d
Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
fiercebiotech
22d
Electra aims for $342M IPO to power inflammatory drug’s push through phase 3
fiercebiotech
22d
The GOP’s $50 billion rural health fund is coming up short, hospital leaders say
stat
22d
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival
fiercebiotech
22d
Unlocking cell surface protein research with site-specific labeling
biospace
22d
Psychedelic therapies ride wave of public favor into FDA hearing
biospace
22d
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
biospace
22d
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
22d
Recon: New FDA oncology chief vows continued innovation in OCE; FDA approves drugs for two rare genetic diseases
raps
22d
Asia-Pacific Roundup: Singapore advances legislation to build ‘more coherent, future-ready’ regulatory system
raps
24d
STAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial
stat
24d
STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss
stat
25d
FDA extends review of Exelixis' colorectal cancer drug candidate
endpoints
25d
Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer
fiercebiotech
← prev
page 8 of 38
next →
